Possible side effects are given below on the descending frequency of occurrence: very often (> 1/10); often (> 1/100 <1/10); sometimes (> 1/1000, <1/100); rarely (> 1/10000, <1/1000); Very rarely (<1/10000), including individual messages, (in accordance with the MedDRA classification).
From the side of the blood and lymphatic system: infrequently, thrombocytopenia.
From the nervous system: hasto - dizziness, headache.
From the side of the hearing organ and labyrinthine disorders: infrequently - vertigo.
On the part of the respiratory system, the organs of the thorax and the mediastinum: often - pharyngitis, rhinitis, bronchitis, cough.
From the side of the digestive tract: often - diarrhea, indigestion, gastroenteritis, abdominal pain, nausea; infrequently - vomiting.
From the skin and subcutaneous tissues: infrequently - exanthema, allergic dermatitis, urticaria, rash, itchy skin; rarely angioedema.
From the side of the musculoskeletal system: often - back pain, bone pain, arthritis; infrequently - myalgia; rarely - muscle cramps.
From the side of the kidneys and urinary tract: often - hematuria, urinary tract infection; rarely acute renal failure, renal insufficiency.
From the side of the cardiovascular system: infrequently - angina pectoris; rarely a marked decrease in blood pressure.
From the side of metabolism and nutrition: often - increasing the concentration of triglycerides in blood plasma, increasing the concentration of uric acid in the blood; rarely - an increase in the concentration of potassium in the blood.
From the immune system: infrequently, anaphylactic reactions.
Common violations: often - chest pain, peripheral edema, flu-like symptoms, weakness; infrequently - edema of the face, asthenia, malaise; rarely - drowsiness.
Other violations: often - increased urea concentration in blood plasma, increased activity of liver enzymes, increased concentration of creatine phosphokinase; rarely - an increase in the concentration of creatinine in the blood plasma.
There have also been reports of single cases of rhabdomyolysis, which was associated with the administration of antagonists of AT-II.
* In elderly patients, arterial hypotension can be observed somewhat more often (from "rarely" to "infrequently").